Prospective Evaluation of Taste Function in Patients With Head and Neck Cancer Receiving Intensity-Modulated Radiotherapy.
Prognostic Significance of Neoadjuvant Rectal Scores in Preoperative Short-Course Radiotherapy and Long-Course Concurrent Chemoradiotherapy for Patients with Locally Advanced Rectal Cancer.
Treatment patterns and survival outcomes of advanced hypopharyngeal squamous cell carcinoma.
Long-term taste impairment after intensity-modulated radiotherapy to treat head-and-neck cancer: correlations with glossectomy and the mean radiation dose to the oral cavity.
Epigenetic therapy regulates the expression of ALDH1 and immunologic response: Relevance to the prognosis of oral cancer.
Inflammation-induced myeloid-derived suppressor cells associated with squamous cell carcinoma of the head and neck.
Mortality in tongue cancer patients treated by curative surgery: a retrospective cohort study from CGRD.
Androgen deprivation increases the risk of fracture in prostate cancer patients: a population-based study in Chinese patients.
Estimation of life expectancy and quality-adjusted life expectancy in non-metastatic nasopharyngeal cancer patients treated by intensity-modulated radiotherapy with or without chemotherapy.
Significance of DNMT3b in oral cancer.
Outcome of Patients with Esophageal Cancer: A Nationwide Analysis.
Scintigraphic assessment of salivary function after intensity-modulated radiotherapy for head and neck cancer: Correlations with parotid dose and quality of life.
Comparison of treatment results between surgery alone, preoperative short-course radiotherapy, or long-course concurrent chemoradiotherapy in locally advanced rectal cancer.
Role of DNA methyltransferase 1 in pharyngeal cancer related to treatment resistance.
Significance of interleukin-6 signaling in the resistance of pharyngeal cancer to irradiation and the epidermal growth factor receptor inhibitor.
Comparison between conventional and intensity-modulated post-operative radiotherapy for stage III and IV oral cavity cancer in term of treatment results and toxicities.
The predictive role of E2-EPF ubiquitin carrier protein in esophageal squamous cell carcinoma.
Adjuvant concurrent chemoradiotherapy with intensity-modulated pelvic radiotherapy after surgery for high-risk, early stage cervical cancer patients.
Clinical outcome in posthysterectomy cervical cancer patients treated with concurrent Cisplatin and intensity-modulated pelvic radiotherapy: comparison with conventional radiotherapy.
Inhibition of lung tumor growth and augmentation of radiosensitivity by decreasing peroxiredoxin I expression.
Differential effects of caffeic acid phenethyl ester for normal lung and lung cancer treated with irradiation: in vitro and in vivo study.
Prediction of poor survival by cyclooxygenase-2 in patients with T4 nasopharyngeal cancer treated by radiation therapy: Clinical and in vitro studies.
Cell killing and radiosensitization by caffeic acid phenethyl ester (CAPE) in lung cancer cells.
The role of radiotherapy in the treatment of early stage glottic cancer.
Concurrent cisplatin, 5-fluorouracil, leucovorin and radiotherapy for invasive bladder cancer.
High-dose-rate sterotactic brachytherapy for patients with newly diagnosed glioblastoma multiformes
Induction of Radioprotective peroxiredoxin-I by ionizing irradiation.
Radiation-induced hearing impairment in patients treated for malignant parotid tumor.
Comparison of radiotherapy and surgical results of early stage glottic cancer: a retrospective analysis.
